Asia's Next Frontier: Building Capabilities for Translational Research
Over the past decade, Asia has experienced great investment in biomedical research and development and, as a result, incredible advances in biomedical innovation. However, large gaps in commercializing research still exist. Is the region prepared to overcome the "Valley of Death" and translate basic research discoveries to commercial success? What is necessary to improve translational research capacity? What can be done to incentivize investments in translational research? What successful financing models are leading the way?
Moderator:
Tanisha Carino Executive Director, FasterCures
Speakers:
Christiana Bardon Managing Director, UBS Oncology Impact Fund, MPM Capital Carl Firth CEO, ASLAN Pharmaceuticals
Annalisa Jenkins Chairman, Cell Medica
Baiju Shah CEO, BioMotiv; Co-Leader, The Harrington Project for Discovery & Development